Arkadios Wealth Advisors Dexcom Inc Transaction History

Arkadios Wealth Advisors

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$129.87 - $162.82 $8,441 - $10,583	-65 Closed	0 $0
Q2 2021 Jul 28, 2021	BUY	$80.99 - $107.93 $1,943 - $2,590	24 Added 58.54%	65 $27,000
Q1 2021 Apr 26, 2021	BUY	$84.79 - $104.74 $84 - $104	1 Added 2.5%	41 $14,000
Q4 2020 Feb 09, 2021	SELL	$78.0 - $104.5 $1,560 - $2,090	-20 Reduced 33.33%	40 $14,000
Q3 2020 Nov 10, 2020	SELL	$95.51 - $112.95 $955 - $1,129	-10 Reduced 14.29%	60 $24.3 Million
Q1 2020 May 14, 2020	BUY	$47.79 - $75.63 $1,099 - $1,739	23 Added 48.94%	70 $18.8 Million
Q4 2019 Feb 14, 2020	BUY	$36.62 - $57.29 $1,721 - $2,692	47 New	47 $2,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Arkadios Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Arkadios Wealth Advisors with notifications on news.